A study to see how well gokshuradi guggulu vati in the management of the asrigdarapatients

A randomised control trial in the management of the asrigdara with the goksuradi guggulu vati - nil

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087009

Enrollment

Registered

2025-05-15

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N926- Irregular menstruation, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient suffering from asrigdara with excessive bleeding.

Exclusion criteria

Exclusion criteria: Patient who are suffering from polyp erosion carcinoma menopausal bleeding with coagulation disorders

Design outcomes

Primary

Measure	Time frame
Study will be effective for patient in the management of asrigdaraTimepoint: Primary outcome will be assessed after 2 months of medicine intervention	—

Secondary

Measure	Time frame
clinical research can be used for making line of treatment for asrigdaraTimepoint: Secondary outcome will be assessed after one year of clinical trails on patients of ashrigdara	—

Countries

India

Contacts

Public ContactDr Trilochan Mohanto

Sri sai ayurvedic pg medical college and hospital aligarh

tmahanta72@gmail.com9993304678

Outcome results